Prescription Required
Bilypsa 4mg Tablet 45s contains Saroglitazar (4mg) and is used to treat dyslipidemia (abnormal lipid levels) and non-alcoholic fatty liver disease (NAFLD). It helps regulate cholesterol and triglyceride levels while improving liver function in patients with metabolic disorders.
Unsafe to consume alcohol with this drug
Bilypsa 4mg Tablet 45s may be unsafe; consult your doctor to weigh benefits and risks.
Use with caution during breastfeeding; consult your doctor.
Generally safe; unlikely to affect your ability to drive.
Limited information available; consult your doctor.
Limited information available; consult your doctor.
Saroglitazar (4mg): A dual PPAR (Peroxisome Proliferator-Activated Receptor) agonist that helps reduce triglycerides, LDL (bad cholesterol), and improves insulin sensitivity. It lowers triglycerides and cholesterol levels while reducing fat accumulation in the liver.
Dyslipidemia: A condition where lipid levels are imbalanced, increasing the risk of cardiovascular diseases. Non-Alcoholic Fatty Liver Disease (NAFLD): A condition where fat accumulates in the liver, potentially leading to liver damage. Metabolic Syndrome: A combination of diabetes, high blood pressure, and abnormal cholesterol levels that increase health risks.
Bilypsa 4mg Tablet 45s is a PPAR agonist used to manage dyslipidemia and NAFLD. It helps reduce triglycerides, control cholesterol levels, and improve liver function, making it beneficial for patients with metabolic disorders.
MBA in pharmaceutical management
Content Updated on
Monday, 24 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA